With partnerships, MoonLion Hemp aims to invest in domestic production
Currently, the company already exports its medications to Brazil for patients with medical prescriptions
In 2020, the American company founded by Brazilians, MoonLion CannaScience, invested $250,000 in creating a new branch of the company focused on marketing products in this segment in Brazil: MoonLion Hemp. The company already has over 600 registered doctors and expects to earn around R$12 million in this first year of operation.
>>> Follow Sechat on INSTAGRAM
Currently, in Brazil, only one company is authorized to produce Cannabis-based medications. In this scenario, MoonLion Hemp, newly arrived in the Brazilian market and specialized in medicines with cannabinoids, aims to be the next company to obtain this authorization certificate from the National Health Surveillance Agency (Anvisa) for the production of its medications in Brazil.
Currently, MoonLion Hemp already exports its medications to Brazil for patients with medical prescriptions in hand. "With the development of our medications in Brazil, we will be able to reduce the entire production chain costs of our product lines. This way, we will reach the end consumer with a quality medication at an affordable price for everyone.", says Danielle de Souza, co-founder of the company.
>>> Join Sechat's group on TELEGRAM and be the first to receive news
MoonLion Hemp has an interested laboratory and believes that they will soon sign the contracts. "We are just studying the best way to bring the raw materials of our products to Brazil", emphasizes Leandro Moraes Pasztor, CEO and founder.
>>> Join Sechat's group on WHATSAPP and be the first to receive news